TY - JOUR
T1 - TGFβ1 and Treg cells
T2 - alliance for tolerance
AU - Bommireddy, Ramireddy
AU - Doetschman, Thomas
N1 - Funding Information:
We apologize to those investigators whose works have not been cited in this review owing to space restrictions. We thank Greg Boivin, University of Cincinnati, for his contributions to the IL-6 unpublished studies mentioned in the review and we thank George Babcock, University of Cincinnati, for consultation and use of his FACS equipment. We acknowledge the support of NIH grants AI067903 and CA084291 to TD.
PY - 2007/11
Y1 - 2007/11
N2 - Transforming growth factor β1 (TGFβ1), an important pleiotropic, immunoregulatory cytokine, uses distinct signaling mechanisms in lymphocytes to affect T-cell homeostasis, regulatory T (Treg)-cell and effector-cell function and tumorigenesis. Defects in TGFβ1 expression or its signaling in T cells correlate with the onset of several autoimmune diseases. TGFβ1 prevents abnormal T-cell activation through the modulation of Ca2+-calcineurin signaling in a Caenorhabditis elegans Sma and Drosophila Mad proteins (SMAD)3 and SMAD4-independent manner; however, in Treg cells, its effects are mediated, at least in part, through SMAD signaling. TGFβ1 also acts as a pro-inflammatory cytokine and induces interleukin (IL)-17-producing pathogenic T-helper cells (Th IL-17 cells) synergistically during an inflammatory response in which IL-6 is produced. Here, we will review TGFβ1 and its signaling in T cells with an emphasis on the regulatory arm of immune tolerance.
AB - Transforming growth factor β1 (TGFβ1), an important pleiotropic, immunoregulatory cytokine, uses distinct signaling mechanisms in lymphocytes to affect T-cell homeostasis, regulatory T (Treg)-cell and effector-cell function and tumorigenesis. Defects in TGFβ1 expression or its signaling in T cells correlate with the onset of several autoimmune diseases. TGFβ1 prevents abnormal T-cell activation through the modulation of Ca2+-calcineurin signaling in a Caenorhabditis elegans Sma and Drosophila Mad proteins (SMAD)3 and SMAD4-independent manner; however, in Treg cells, its effects are mediated, at least in part, through SMAD signaling. TGFβ1 also acts as a pro-inflammatory cytokine and induces interleukin (IL)-17-producing pathogenic T-helper cells (Th IL-17 cells) synergistically during an inflammatory response in which IL-6 is produced. Here, we will review TGFβ1 and its signaling in T cells with an emphasis on the regulatory arm of immune tolerance.
UR - http://www.scopus.com/inward/record.url?scp=36048956108&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=36048956108&partnerID=8YFLogxK
U2 - 10.1016/j.molmed.2007.08.005
DO - 10.1016/j.molmed.2007.08.005
M3 - Review article
C2 - 17977791
AN - SCOPUS:36048956108
SN - 1471-4914
VL - 13
SP - 492
EP - 501
JO - Trends in Molecular Medicine
JF - Trends in Molecular Medicine
IS - 11
ER -